Delivering mitochondrial health
I mitten av maj medverkar Abliva vid mötet Bio€quity Europe i San Sebastán, Spanien. "For more than 20 years, Bio€quity Europe has been where CEOs and investors gather to network, partner, and debate critical issues facing the biotech industry." Ablivas VD Ellen Donnelly kommer bland annat att presentera bolaget under eventet. Följ länken nedan för […]
Join Abliva for a virtual KOL event featuring Amel Karaa, MD (Massachusetts General Hospital), who will discuss the unmet medical need and current treatment landscape for patients with primary mitochondrial disease. There are currently no approved medicines for the systemic disease. The event will focus on Abliva's lead program, KL1333, which has shown clinically meaningful, […]
I början av juni reser Ablivas VD Ellen Donnelly till San Diego för att medverka vid och presentera bolaget på BIO International 2024. Följ länken nedan för mer information.
I slutet av juni kommer Abliva att medverka vid den amerikanska patientorganisationen UMDS:s Mitochondrial Disease Conference i Cleveland, Ohio. "Each year, UMDF’s Mitochondrial Medicine Conference brings together the best minds in mitochondrial medicine and the patients we serve. With over 700 attendees representing almost every state in the U.S. and more than 15 different countries, […]